Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Miami
With
Astellas Pharma Inc
This is a randomized, prospective single center study evaluating the two maintenance drugs above.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with Type 1 diabetes and end stage renal disease.
Women of childbearing potential must have had a negative pregnancy test (serum or urine).
Patient agrees to participate in the study and sign an informed consent.
Patient has no known contraindication to the administration of rapamycin or mycophenolate mofetil.
Patient has no history of hypersensitivity to rapamycin or mycophenolate mofetil.
You may not be if
Patient has history of a malignancy within two years, with the exception of adequately treated localized squamous or basal cell carcinoma of the skin without evidence of recurrence.
Patient is currently abusing drugs or alcohol.
Patient is known or suspected to have an active infection or be seropositive for hepatitis B surface antigen (HBsAg), hepatitis C (HCV) or human immunodeficiency virus (HIV).
